Please assess the completion status of the following clinical trial:

Trial Title: A Study to Compare the Effectiveness and Safety of Fesoterodine and Placebo in an Elderly Population of Patients Who go to the Toilet Very Frequently Due to Overactive Bladder.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female ≥65 years old.~* Overactive bladder symptoms for at least 3 months prior to study start.~* Eight or more micturitions per 24 hours as confirmed by diary records~Exclusion Criteria:~* Predominant Stress Urinary Incontinence~* Active or recurrent bladder infections~* Other bladder and genital conditions that could be the predominant cause of symptoms or interfere with treatment assessment and success.

- Gender: ALL
- Minimum Age: 65 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: ACTIVE_COMPARATOR): Flexible dose regimen of placebo once daily. The dose can be increased after 4 weeks if clinically indicated. Subsequently the dose can be reduced to the original dose if clinically indicated.
- Fesoterodine (Type: ACTIVE_COMPARATOR): Flexible dose regimen of fesoterodine fumarate 4mg once daily. The dose can be increased to 8mg once daily after 4 weeks if clinically indicated. Subsequently the dose can be reduced to 4mg if clinically indicated.

Based on this trial design, predict the completion outcome and termination type (if applicable).